Literature DB >> 18542937

Impaired heart rate variability and altered cardiac sympathovagal balance after antidepressant overdose.

W S Waring1, J Y Rhee, D N Bateman, G E Leggett, H Jamie.   

Abstract

PURPOSE: Antidepressant overdose may be associated with significant cardiotoxicity, and recent data have shown that acute toxic effects are associated with impaired heart rate variability. This study was designed to examine the feasibility of non-invasive heart rate variability recording in patients that present to hospital after deliberate antidepressant ingestion.
METHODS: This was a prospective study of 72 consecutive patients attending the Emergency Department after deliberate antidepressant overdose and 72 age-matched patients that ingested paracetamol, as a control group. Single time-point continuous electrocardiographic recordings were used to allow spectral analyses of heart rate variability determined in low-frequency (LF) and high-frequency (HF) domains. The LF:HF ratio was used to represent overall sympathovagal cardiac activity.
RESULTS: Antidepressant overdose was associated with reduced overall heart rate variability: 1329 vs. 2018 ms(2) (P = 0.0239 by Mann-Whitney test). Variability in the LF domain was higher (64.8 vs. 49.8, P = 0.0006), whereas that in the HF domain was lower (24.3 vs. 36.4, P = 0.0001), and the LF:HF ratio was higher in the antidepressant group (2.4 vs. 1.2, P = 0.0003).
CONCLUSIONS: Antidepressant overdose is associated with impaired heart rate variability in a pattern consistent with excess cardiac sympathetic activity. Further work is required to establish the significance of these findings and to explore whether the impairment of heart rate variability may be used to predict the development of arrhythmia in this patient group.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18542937     DOI: 10.1007/s00228-008-0505-7

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  36 in total

Review 1.  Time domain measurements of heart rate variability.

Authors:  R E Kleiger; P K Stein; M S Bosner; J N Rottman
Journal:  Cardiol Clin       Date:  1992-08       Impact factor: 2.213

2.  Heart rate variability reveals risk of arrhythmias after intoxication with antidepressants.

Authors:  Ina Djonlagic; Hasib Djonlagic; Thomas Kibbel; Sven Suefke; Christoph Dodt
Journal:  Intensive Care Med       Date:  2006-11-16       Impact factor: 17.440

3.  The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions.

Authors:  Kyoung-Bok Min; Jin-Young Min; Domyung Paek; Sung-Il Cho
Journal:  Pacing Clin Electrophysiol       Date:  2008-05       Impact factor: 1.976

4.  High concentrations of tricyclic antidepressants increase intracellular Ca2+ in cultured neural cells.

Authors:  P G Joshi; A Singh; B Ravichandra
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

Review 5.  Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials.

Authors:  J Robert Swenson; Steve Doucette; Dean Fergusson
Journal:  Can J Psychiatry       Date:  2006-12       Impact factor: 4.356

6.  A meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose.

Authors:  Benoit Bailey; Nicholas A Buckley; Devendra K Amre
Journal:  J Toxicol Clin Toxicol       Date:  2004

7.  Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.

Authors:  Alexander H Glassman; J Thomas Bigger; Michael Gaffney; Louis T Van Zyl
Journal:  Arch Gen Psychiatry       Date:  2007-09

8.  Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.

Authors:  Alan D Woolf; Andrew R Erdman; Lewis S Nelson; E Martin Caravati; Daniel J Cobaugh; Lisa L Booze; Paul M Wax; Anthony S Manoguerra; Elizabeth J Scharman; Kent R Olson; Peter A Chyka; Gwenn Christianson; William G Troutman
Journal:  Clin Toxicol (Phila)       Date:  2007       Impact factor: 4.467

9.  Mechanism of block of cardiac transient outward K+ current (I(to)) by antidepressant drugs.

Authors:  O Casis; J A Sánchez-Chapula
Journal:  J Cardiovasc Pharmacol       Date:  1998-10       Impact factor: 3.105

10.  Incidence of Brugada electrocardiographic pattern and outcomes of these patients after intentional tricyclic antidepressant ingestion.

Authors:  Vikhyat S Bebarta; Scott Phillips; Aaron Eberhardt; K J Calihan; Javier C Waksman; Kennon Heard
Journal:  Am J Cardiol       Date:  2007-06-26       Impact factor: 2.778

View more
  5 in total

1.  Clinical use of antidepressant therapy and associated cardiovascular risk.

Authors:  W Stephen Waring
Journal:  Drug Healthc Patient Saf       Date:  2012-08-17

2.  Comment on "Serial monitoring of lead aVR in patients with prolonged unconsciousness following tricyclic antidepressant overdose".

Authors:  Hossein Sanaei-Zadeh
Journal:  Psychiatry Investig       Date:  2012-01-18       Impact factor: 2.505

Review 3.  Cardiovascular considerations in antidepressant therapy: an evidence-based review.

Authors:  Habibeh Yekehtaz; Mehdi Farokhnia; Shahin Akhondzadeh
Journal:  J Tehran Heart Cent       Date:  2013-10-28

4.  Heart rate variability in children with tricyclic antidepressant intoxication.

Authors:  Ener Cagri Dinleyici; Zubeyir Kilic; Sabiha Sahin; Rabia Tutuncu-Toker; Makbule Eren; Zeynel Abidin Yargic; Pelin Kosger; Birsen Ucar
Journal:  Cardiol Res Pract       Date:  2013-03-05       Impact factor: 1.866

5.  Differential Effects of Focused Attention and Open Monitoring Meditation on Autonomic Cardiac Modulation and Cortisol Secretion.

Authors:  Yuuki Ooishi; Masahiro Fujino; Vimala Inoue; Michio Nomura; Norimichi Kitagawa
Journal:  Front Physiol       Date:  2021-07-15       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.